An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus.
The efficient release of newly assembled retrovirus particles from the plasma membrane requires the recruitment of a network of cellular proteins (ESCRT machinery) normally involved in the biogenesis of multivesicular bodies and in cytokinesis. Retroviruses and other enveloped viruses recruit the ESCRT machinery through three classes of short amino acid consensus sequences termed late domains: PT/SAP, PPXY, and LYPX(n)L. The major late domain of Rous sarcoma virus (RSV) has been mapped to a PPPY motif in Gag that binds members of the Nedd4 family of ubiquitin ligases. RSV Gag also contains a second putative late domain motif, LYPSL, positioned 5 amino acids downstream of PPPY. LYPX(n)L motifs have been shown to support budding in other retroviruses by binding the ESCRT adaptor protein Alix. To investigate a possible role of the LYPSL motif in RSV budding, we constructed PPPY and LYPSL mutants in the context of an infectious virus and then analyzed the budding rates, spreading profiles, and budding morphology. The data imply that the LYPSL motif acts as a secondary late domain and that its role in budding is amplified in the absence of a fully functional PPPY motif. The LYPXL motif proved to be a stronger late domain when an aspartic acid was substituted for the native serine, recapitulating the properties of the LYPDL late domain of equine infectious anemia virus. The overexpression of human Alix in the absence of a fully functional PPPY late domain partially rescued both the viral budding rate and viral replication, supporting a model in which the RSV LYPSL motif mediates budding through an interaction with the ESCRT adaptor protein Alix.
Dilley
Kari A
KA
Department of Molecular Biology and Genetics, Biotech Bldg., Cornell University, Ithaca, NY 14853, USA.
Gregory
Devon
D
Johnson
Marc C
MC
Vogt
Volker M
VM
D019943:Amino Acid Substitution; D000818:Animals; D002135:Calcium-Binding Proteins / Q000378:metabolism; D018797:Cell Cycle Proteins / Q000378:metabolism; D002460:Cell Line; D002645:Chickens; D056827:Endosomal Sorting Complexes Required for Transport / Q000378:metabolism; D015683:Gene Products, gag / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D016297:Mutagenesis, Site-Directed; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D052736:Rous sarcoma virus / Q000502:physiology*; D057074:Virus Release; D014779:Virus Replication
D002135:Calcium-Binding Proteins; D018797:Cell Cycle Proteins; D056827:Endosomal Sorting Complexes Required for Transport; D015683:Gene Products, gag; C117020:PDCD6IP protein, human
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9
2014240
J Virol. 2003 Nov;77(22):11882-95
14581525
Nat Rev Mol Cell Biol. 2004 Apr;5(4):317-23
15071556
J Virol. 2002 Feb;76(4):1569-77
11799151
J Virol. 2002 Jan;76(1):105-17
11739676
J Virol. 2009 Jul;83(14):7185-93
19403673
Biochem Soc Trans. 2009 Feb;37(Pt 1):181-4
19143627
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6
11095724
J Virol. 2004 Feb;78(3):1503-12
14722305
J Virol. 2003 Sep;77(17):9474-85
12915562
Nat Struct Mol Biol. 2008 Jan;15(1):43-9
18066081
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9
14519844
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204
11562473
PLoS Pathog. 2009 Mar;5(3):e1000339
19282983
J Virol. 2008 Feb;82(3):1610-4
18057258
Methods Cell Biol. 1997;52:179-214
9379950
Cell. 2001 Oct 5;107(1):55-65
11595185
J Virol. 2004 Dec;78(24):13943-53
15564502
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8
16230638
Virology. 2006 Jan 5;344(1):55-63
16364736
Cell. 2007 Mar 9;128(5):841-52
17350572
Retrovirology. 2006 Nov 03;3:77
17083721
Virology. 2008 Jun 5;375(2):637-45
18355887
J Cell Biol. 2005 Jan 3;168(1):89-101
15623582
J Virol. 2008 Oct;82(19):9770-5
18667521
Virology. 1991 Nov;185(1):99-108
1656608
J Biol Chem. 2007 Feb 9;282(6):3847-55
17158451
Retrovirology. 2008 May 13;5:39
18477395
Virus Res. 2004 Dec;106(2):87-102
15567490
J Virol. 2007 Jun;81(12):6614-22
17428861
Cell. 2003 Sep 19;114(6):689-99
14505569
J Virol. 2004 Jun;78(11):5554-63
15140952
J Virol. 1995 Sep;69(9):5455-60
7636991
PLoS Biol. 2009 Jul;7(7):e1000163
19636361
J Virol. 1994 Oct;68(10):6605-18
8083996
Nat Struct Mol Biol. 2007 Mar;14(3):194-9
17277784
J Virol. 1996 Aug;70(8):5695-700
8764091
Dev Cell. 2005 Jun;8(6):937-47
15935782
J Virol. 2003 Feb;77(3):1812-9
12525615
J Virol. 2006 Oct;80(19):9634-40
16973567
Science. 2007 Jun 29;316(5833):1908-12
17556548
Virology. 2002 Oct 25;302(2):405-12
12441084
Nature. 2008 Jul 10;454(7201):236-40
18500329
Traffic. 2005 Oct;6(10):880-94
16138902
Nat Rev Microbiol. 2007 Dec;5(12):912-6
17982468
J Virol. 1992 Jan;66(1):6-11
1309264
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60
11805336
J Virol. 2000 Aug;74(16):7250-60
10906179
J Virol. 2003 Nov;77(22):12373-7
14581576
J Virol. 2008 Feb;82(3):1389-98
18032513
Virology. 2009 Sep 1;391(2):284-92
19596386
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9
11427703
J Virol. 2005 Mar;79(5):2988-97
15709019
Virology. 2006 Mar 30;347(1):226-33
16406458
Nat Med. 2001 Dec;7(12):1313-9
11726971
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10541-6
18641129
J Virol. 1997 Sep;71(9):6541-6
9261374
J Virol. 2005 Jul;79(14):9038-45
15994797